Vizamyl
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Lilja, J. 2017. [F]Flutemetamol PET image processing, visualization and quantification targeting clinical routine. Digital…
Medicare’s decision to restrict coverage of florbetapir, a diagnostic agent for Alzheimer’s disease, exemplifies an inconsistent…
2013年10月25日，美国食品药品监督管理局（FDA）批准由GE Healthcare Ltd的分公司Medi—Physics生产的放射性诊断药物[18F]flutemetamol注射液（Vizamyl）在美国上市。
Recent advances along clinical and neuropathological lines, as well as in our ability to detect the deposition of β-amyloid (A…
There has been tremendous excitement regarding biomarkers that provide in vivo information on neurodegenerative diseases. Until…